A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...

HIV-1, like other viruses, lacks the machinery to produce ... offering a promising new avenue for antiviral drug development”, reports Caliskan. Redmond Smyth, a former Helmholtz Young Investigator ...

preventing HIV from integrating its genetic material into the host's DNA. Drug Resistance Mutations (DRMs): Genetic changes in the virus that reduce the effectiveness of antiviral drugs.

HIV-1, like other viruses ... offering a promising new avenue for antiviral drug development," reports Caliskan. Redmond Smyth, a former Helmholtz Young Investigator Group Leader at the HIRI ...

HIV-1, like other viruses ... offering a promising new avenue for antiviral drug development”, reports Caliskan. The researchers also observed that ribosomes collide at specific regions of ...

“Somebody needs to take away whatever drugs the committee is on,” wrote Kristian Andersen, a virologist at Scripps Institute, on Bluesky. Boghuma Titanji, an HIV researcher at Emory ...

Others have voiced a similar sentiment: "The staggering success in developing drugs against HIV is an example of how efficiently effective antivirals can be developed given appropriate funding".

The new administration's freeze on foreign aid (affecting America's sweeping anti-HIV initiative PEPFAR) has raised concerns ...

With antivirals coming off patent, and the fact that HIV medications are second only to psychiatric medications in total expense to most US correctional facilities, many more expensive fixed-dose ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...